Respiratorisches Syncytial-virus (RSV)-Infektion: Massnahmen beim immunsupprimierten Patienten. [Respiratory syncytial virus infections: measures in immunocompromised patients]

Details

Serval ID
serval:BIB_05755E60052D
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Respiratorisches Syncytial-virus (RSV)-Infektion: Massnahmen beim immunsupprimierten Patienten. [Respiratory syncytial virus infections: measures in immunocompromised patients]
Journal
Schweizerische Rundschau fur Medizin Praxis
Author(s)
Hirsch  H. H., Steffen  I., Francioli  P., Widmer  A. F.
ISSN
1013-2058 (Print)
Publication state
Published
Issued date
01/2006
Volume
95
Number
3
Pages
61-6
Notes
Comparative Study
English Abstract
Journal Article
Review --- Old month value: Jan 18
Abstract
RSV infections are an annually recurring problem of significant morbiditiy and mortality in the immunocompromised host, especially after lung and stem cell transplantation. The effectiveness of hygienic (isolation) and therapeutic (ribavirin, immunoglobulin, pavilizumab) measures depends of high index of suspicion and rapid diagnostic confirmation by the antigen test, PCR and/or culture. Allocation of resources require stratification of measures according to the known or estimated risk for complications.
Keywords
Adult Antibodies, Monoclonal/administration & dosage/therapeutic use Antiviral Agents/administration & dosage/therapeutic use Child Drug Therapy, Combination Humans *Immunocompromised Host Immunoglobulins, Intravenous/therapeutic use *Respiratory Syncytial Virus Infections/diagnosis/drug therapy/prevention & control/therapy Ribavirin/administration & dosage/therapeutic use Risk Factors Stem Cell Transplantation Time Factors
Pubmed
Create date
25/01/2008 17:07
Last modification date
20/08/2019 12:27
Usage data